TherapeuticsMD
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- $22.1M
- Introduction
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
Clinical Trials
6
Trial Phases
3 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Annovera™ Drug-Drug Interaction Study
- Conditions
- WomenContraception
- Interventions
- First Posted Date
- 2020-02-28
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 67
- Registration Number
- NCT04290390
- Locations
- 🇨🇦
Syneos Health, Quebec City, Quebec, Canada
The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
- Conditions
- Contraception
- Interventions
- Other: Tampon
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 21
- Registration Number
- NCT04272008
- Locations
- 🇺🇸
University of Pennsylvania Women's Health Clinical Research Center, Philadelphia, Pennsylvania, United States
🇨🇦Syneos Health, Québec City, Quebec, Canada
TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
- Conditions
- MenopauseDyspareuniaVulvovaginal AtrophyPainful Intercourse
- Interventions
- Drug: placebo
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 50
- Registration Number
- NCT02449902
- Locations
- 🇺🇸
Avail Clinical Research, DeLand, Florida, United States
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
- Conditions
- DyspareuniaVulvovaginal AtrophyMenopausePainful Intercourse
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 764
- Registration Number
- NCT02253173
- Locations
- 🇺🇸
Medical Affiliated Research Center, Huntsville, Alabama, United States
🇺🇸Montogomery Women's Health, Montgomery, Alabama, United States
🇺🇸Cactus Clinical Research, Mesa, Arizona, United States
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 6
- Registration Number
- NCT02019589
- Locations
- 🇺🇸
Precision Trials/New Horizons Women's Care, Chandler, Arizona, United States
🇺🇸Precision Clinical Trials/Arizona Wellness Center for Women, Phoenix, Arizona, United States
🇺🇸Visions Clinical Research, Tucson, Arizona, United States
- Prev
- 1
- 2
- Next